Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.470
+0.014 (2.98%)
Nov 21, 2024, 4:00 PM EST - Market closed

Turnstone Biologics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21
Net Income
-74.42-55.2-30.8333.27
Depreciation & Amortization
2.162.83.91.39
Loss (Gain) From Sale of Assets
-0.32--
Asset Writedown & Restructuring Costs
1.581.580.5-
Loss (Gain) From Sale of Investments
-2.71-2.06-0.10.54
Stock-Based Compensation
4.064.226.422.61
Other Operating Activities
-1.690.117.022.31
Change in Accounts Receivable
0.228.53-2.01-2.37
Change in Accounts Payable
-1.82-3.43.41-2.16
Change in Unearned Revenue
--19.31-53.1-81.94
Change in Income Taxes
-0---0.1
Change in Other Net Operating Assets
6.16-3.75-6.260.81
Operating Cash Flow
-66.47-66.15-71.06-45.63
Capital Expenditures
-0.25-1.25-5.17-3.41
Sale of Property, Plant & Equipment
0.30.45--
Investment in Securities
51.93-27.3-9.760.06
Investing Cash Flow
51.98-28.09-14.93-3.35
Issuance of Common Stock
-77.940.160.34
Other Financing Activities
-0.03-0.9-2.81-
Financing Cash Flow
-0.1677.05-2.6679.95
Net Cash Flow
-14.64-17.2-88.6530.98
Free Cash Flow
-66.71-67.4-76.23-49.04
Free Cash Flow Margin
--349.12%-104.00%-48.41%
Free Cash Flow Per Share
-2.89-5.83-30.68-18.16
Cash Income Tax Paid
0.10.10.082.01
Levered Free Cash Flow
-41.86-45.82-31.3-
Unlevered Free Cash Flow
-41.86-45.82-31.3-
Change in Net Working Capital
-4.9914.7621.07-
Source: S&P Capital IQ. Standard template. Financial Sources.